Luis M. Montuenga, PhD, on Noninvasive Biomarkers in Lung Cancer Screening

February 09, 2021 By The ASCO Post Staff

Luis M. Montuenga, PhD, of the University of Navarra, discusses the potential contributions of biomarkers, promising biomarker panels being tested and published, the need to standardize biospecimen collection, and how to improve the sensitivity of these biomarkers (Abstract PL05.06).

Related Content